The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond ...
Novo Nordisk said an older version of its weight-loss drug semaglutide failed to meet its main goal in late-stage trials ...
GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...
A meta-analysis found that antiobesity drugs — with the exception of coagonists — did not reduce the risk for overall or site ...
Telehealth companies are aggressively marketing GLP-1s as cosmetic elixirs for anyone who wants to lose a few pounds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback